Navigator Medicines, Inc. raised $100M in a Series A funding round co-led by RA Capital Management and Forbion to advance their bispecific antibody NAV-240 for autoimmune diseases.
Amount Raised
$100 Million
Round Type
Series A
United StatesBiotechnologyHealth CareTherapeuticsInvestors
Description
Navigator Medicines, Inc. has successfully closed a $100 million Series A financing to further develop NAV-240, a bispecific antibody targeting OX40L and TNFα. The funding will accelerate the clinical development of this innovative therapeutic and enhance their broader pipeline of immune regulation biologics.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Navigator Medicines that raised within 45 days of this round, from Fundz verified event records.
- NewcelX raised $7.2M on October 11, 2024.
- Booster Therapeutics raised $15M (Angel) on October 10, 2024.
- Orasis Pharmaceuticals raised $78M (Series D) on October 10, 2024.
- MONCYTE Health raised $1.1M (Seed) on October 8, 2024.
- City Therapeutics raised $135M (Series A) on October 8, 2024.
- Rege Nephro Ltd raised $151M (Series B) on October 7, 2024.
Who to call at Navigator Medicines, and when
A new round usually means Navigator Medicines is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Navigator Medicines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Navigator Medicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Navigator Medicines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Navigator Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNavigator Medicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.